CohBar, Inc.
DelistedCIK 1522602fmd_0MSX46FJKW92PKSD62SXSEP11JManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Jun 30, 2023, 38 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|---|---|---|---|
| Net interest income | – | – | – | – | – | – | 0 | 0 | 0 |
| Research and development | 1 | 2 | 4 | 7 | 10 | 7 | 7 | 8 | 6 |
| Total operating expenses | 2 | 4 | 6 | 10 | 15 | 13 | 13 | 15 | 12 |
| Operating income | (2) | (4) | (6) | (10) | (15) | (13) | (13) | (15) | (12) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | (0) | (0) | 0 | 0 | (0) | (0) | (3) | (0) | 0 |
| Net income | (2) | (4) | (6) | (10) | (16) | (13) | (16) | (15) | (12) |